Behavioral Economics Can Help Cancer Patients Quit Smoking : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
Real-world data suggest that lung cancer patients with uncommon EGFR mutations may benefit from treatment with immune checkpoint inhibitors.
Investigators found that imatinib maintenance therapy for 6 years reduced the risk of recurrence in patients with gastrointestinal stromal tumors.
Niu et al. identify a lipid-laden CAF subset marked by ABCA8a in Setd2-deficient pancreatic tumors, which transports lipids and metabolically sustains tumor growth via OXPHOS. Both…
Assisting Healthcare Providers with Expanded Access Requests for Investigational Oncology Products
On December 14, 2023, the hypoxia-inducible factor inhibitor belzutifan (Welireg) was approved for patients with unresectable locally advanced or metastatic clear cell renal cell carcinoma…
Melanoma is often detected later in people with darker skin complexions and the consequences can be devastating, a Mayo Clinic study reveals.
Tiffany Bostwick, P.A., discussed the importance of communication and education around adverse effects for both oncology nurses and for patients with advanced endometrial cancer who…
“How often do you receive financial support from parents or other relatives?” To access this subscriber-only content please log in or renew your subscription.Looking for…
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care